Ipilimumab vs Levodopa
Ipilimumab vs Levodopa: Overview
This comparison examines the pharmacological differences between Ipilimumab and Levodopa.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Levodopa: Metabolic precursor of dopamine that crosses the BBB.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Levodopa β 1.5 hours.
Chemical Properties
Molecular Formula: Levodopa β C9H11NO4.
Molecular Weight: Levodopa β 197.1880 g/mol.
Type: Ipilimumab β Antibody; Levodopa β Small molecule.